The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice
Open accessAbstract
Insulin resistance is a major factor in the pathogenesis of type 2 diabetes and may be related to alterations in fat metabolism. Fatless mice have been created using dominant-negative protein (A-ZIP/F-1) targeted gene expression in the adipocyte and shown to develop diabetes. To understand the mechanism responsible for the insulin resistance in these mice, we conducted hyperinsulinemic-euglycemic clamps in awake fatless and wild type littermates before the development of diabetes and examined insulin action and signaling in muscle and liver. We found the fatless mice to be severely insulin-resistant, which could be attributed to defects in insulin action in muscle and liver. Both of these abnormalities were associated with defects in insulin activation of insulin receptor substrate-1 and -2-associated phosphatidylinositol 3-kinase activity and a 2-fold increase in muscle and liver triglyceride content. We also show that upon transplantation of fat tissue into these mice, triglyceride content in muscle and liver returned to normal as does insulin signaling and action. In conclusion, these results suggest that the development of insulin resistance in type 2 diabetes may be due to alterations in the partitioning of fat between the adipocyte and muscle/liver leading to accumulation of triglyceride in the latter tissues with subsequent impairment of insulin signaling and action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies by our group (9, 17-20) and others (7, 21, 22) have demonstrated a strong relationship between triglyceride content in liver and muscle and insulin resistance in these tissues.”
From Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy (2002) · cites this paper as [19]
In the citing paper
“recent studies have demonstrated that NAFLD-induced hepatic insulin resistance is a major factor responsible for the transition from normoglycemia to fasting hyperglycemia and T2DM (18–23).”
From The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome (2007) · cites this paper as [18]
In the citing paper
“NAFLD is strongly linked to hepatic insulin resistance”
From The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome (2007) · cites this paper as [18]
In the citing paper
“There is increasing evidence for a causal relationship between hepatic steatosis and hepatic insulin resistance both in rodent models with hepatic steatosis and in patients with nonalcoholic fatty liver disease (4, 18-25).”
From Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men (2006) · cites this paper as [24]
Citations
Cites
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
Mechanism of free fatty acid-induced insulin resistance in humans.
Roden, M., Price, T. B., Perseghin, G., Petersen, K. F., Rothman, D. L., Cline, G. W., & Shulman, G. I. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118742 · Cited by 1,539
Self-citationDresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
Self-citationGriffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Self-citationKrssak, M., Falk Petersen, K., Dresner, A., DiPietro, L., Vogel, S. M., Rothman, D. L., Shulman, G. I., & Roden, M. (1999) · Diabetologia · doi:10.1007/s001250051123 · Cited by 1,264
Self-citationSkeletal Muscle Triglyceride Levels Are Inversely Related to Insulin Action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diab.46.6.983 · Cited by 1,179
Skeletal muscle triglyceride levels are inversely related to insulin action
Pan, D. A., Lillioja, S., Kriketos, A. D., Milner, M. R., Baur, L. A., Bogardus, C., Jenkins, A. B., & Storlien, L. H. (1997) · Diabetes · doi:10.2337/diabetes.46.6.983 · Cited by 1,179
Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy
Shimomura, I., Hammer, R. E., Ikemoto, S., Brown, M. S., & Goldstein, J. L. (1999) · Nature · doi:10.1038/43448 · Cited by 1,038
Research works printed but not linked: 2
- Ohshima, 1984, Am. J. Physiol., 246, E193
- Previs, 1999, Diabetes, 48, A51
Cited by
Sorted by citations
Items 201–300 of 441
Malaisse, W. J. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.836 · Cited by 65
Diet, obesity and diabetes: a current update
Walker, C. G., Zariwala, M. G., Holness, M. J., & Sugden, M. C. (2006) · Clinical Science · doi:10.1042/cs20060150 · Cited by 62
Goedeke, L., Peng, L., Montalvo-Romeral, V., Butrico, G. M., Dufour, S., Zhang, X.-M., Perry, R. J., Cline, G. W., Kievit, P., Chng, K., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aay0284 · Cited by 63
Self-citationCLOCK promotes 3T3‐L1 cell proliferation via Wnt signaling
Zhu, Z., Hua, B., Xu, L., Yuan, G., Li, E., Li, X., Sun, N., Yan, Z., Lü, C., & Qian, R. (2016) · IUBMB Life · doi:10.1002/iub.1512 · Cited by 64
Goralski, K. B., & Sinal, C. J. (2007) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y06-092 · Cited by 66
Zhao, H., Yakar, S., Gavrilova, O., Sun, H., Zhang, Y., Kim, H., Setser, J., Jou, W., & LeRoith, D. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2901 · Cited by 64
Self-citationVisceral fat: A key mediator of NAFLD development and progression
Bansal, S., Vachher, M., Arora, T. K., Kumar, B., & Burman, A. (2023) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2023.200210 · Cited by 69
Korach-André, M., Gao, J., Gounarides, J., Deacon, R. W., Islam, A. H. M. W., & Laurent, D. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00089.2004 · Cited by 60
Divi, S. M., Bellamkonda, R., & Dasireddy, S. K. (2012) · Cited by 61
Segovia, S. A., Vickers, M. H., & Reynolds, C. M. (2017) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174417000204 · Cited by 65
Increasing Adipocyte Lipoprotein Lipase Improves Glucose Metabolism in High Fat Diet-induced Obesity
Walton, R. G., Zhu, B., Ünal, R., Spencer, M. L., Sunkara, M., Morris, A. J., Charnigo, R. J., Katz, W. S., Daugherty, A., Howatt, D. A., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.628487 · Cited by 61
Leptin in congenital and HIV-associated lipodystrophy
Tsoukas, M. A., Farr, O. M., & Mantzoros, C. S. (2014) · Metabolism · doi:10.1016/j.metabol.2014.07.017 · Cited by 58
Thiazolidinediones and the liver in humans
Yki‐Järvinen, H. (2009) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283321d37 · Cited by 60
Uniting epidemiology and experimental models: pancreatic steatosis and pancreatic cancer
Truong, E., Pandol, S. J., & Jeon, C. Y. (2022) · EBioMedicine · doi:10.1016/j.ebiom.2022.103996 · Cited by 58
Yang, S. J., IglayReger, H. B., Kadouh, H. C., & Bodary, P. F. (2009) · Diabetologia · doi:10.1007/s00125-009-1309-8 · Cited by 60
Cortés, V., Cautivo, K. M., Rong, S., Garg, A., Horton, J. D., & Agarwal, A. K. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m045799 · Cited by 64
A-ZIP/F-1 mice lacking white fat: a model for understanding lipoatrophic diabetes
Reitman, M. L., & Gavrilova, O. (2000) · International Journal of Obesity · doi:10.1038/sj.ijo.0801493 · Cited by 57
Self-citationHyperinsulinemic-euglycemic Clamps in Conscious, Unrestrained Mice
Ayala, J. E., Bracy, D. P., Malabanan, C. M., James, F. D., Ansari, T., Fueger, P. T., McGuinness, O. P., & Wasserman, D. H. (2011) · Journal of Visualized Experiments · doi:10.3791/3188-v · Cited by 56
Ectopic visceral fat: A clinical and molecular perspective on the cardiometabolic risk
Mathieu, P., Boulanger, M., & Després, J. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9299-3 · Cited by 56
Increasing muscle mass to improve metabolism
McPherron, A. C., Guo, T., Bond, N. D., & Gavrilova, O. (2013) · Adipocyte · doi:10.4161/adip.22500 · Cited by 59
Self-citationThe Effect of High Fat Diet on Cerebrovascular Health and Pathology: A Species Comparative Review
Zimmerman, B., Kundu, P., Rooney, W. D., & Raber, J. (2021) · Molecules · doi:10.3390/molecules26113406 · Cited by 53
Pennisi, P., Gavrilova, O., Setser-Portas, J., Jou, W., Santopietro, S., Clemmons, D., Yakar, S., & LeRoith, D. (2006) · Endocrinology · doi:10.1210/en.2005-1556 · Cited by 51
Self-citationCariou, B. (2022) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14651 · Cited by 57
Opposite Effects of Background Genotype on Muscle and Liver Insulin Sensitivity of Lipoatrophic Mice
Colombo, C., Haluzı́k, M., Cutson, J. J., Dietz, K. R., Marcus‐Samuels, B., Vinson, C., Gavrilova, O., & Reitman, M. L. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207665200 · Cited by 51
Self-citationLiver and insulin resistance: New wine in old bottle!!!
Patel, B. M., & Goyal, R. K. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172657 · Cited by 51
Janssen, J. A. M. J. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105488 · Cited by 70
Lack of adipocyte purinergic P2Y 6 receptor greatly improves whole body glucose homeostasis
Jain, S., Pydi, S. P., Toti, K. S., Robaye, B., Idzko, M., Gavrilova, O., Wess, J., & Jacobson, K. A. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2006578117 · Cited by 50
Self-citationNon-alcoholic fatty liver disease: From insulin resistance to mitochondrial dysfunction
Herruzo, J. A. S., Ruiz, I. G., Carreras, M. P., & Muñoz-Yagüe, M. T. (2006) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082006001100006 · Cited by 48
Allister, C. A., Liu, L.-F., Lamendola, C. A., Craig, C. M., Cushman, S. W., Hellerstein, M. K., & McLaughlin, T. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m052860 · Cited by 50
Posadas‐Sánchez, R., López-Uribe, Á. R., Posadas‐Romero, C., Pérez‐Hernández, N., Rodrı́guez-Pérez, J. M., Ocampo-Arcos, W. A., Fragoso, J. M., Cardoso-Saldaña, G. C., & Vargas‐Alarcón, G. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.08.008 · Cited by 48
Canoy, D., Wareham, N. J., Luben, R., Welch, A. A., Bingham, S. A., Day, N., & Khaw, K. (2006) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.12.027 · Cited by 47
Chen, M., Haluzı́k, M., Wolf, N. J., Lorenzo, J., Dietz, K. R., Reitman, M. L., & Weinstein, L. S. (2004) · Endocrinology · doi:10.1210/en.2004-0038 · Cited by 47
Self-citationKim, C. S., Park, J., Park, J. S., Kang, E. S., Ahn, C. W., Cha, B., Lim, S., Kim, K.-R., & Lee, H. (2006) · Obesity · doi:10.1038/oby.2006.133 · Cited by 46
Adipokines in the HIV/HAART-associated lipodystrophy syndrome
Paruthi, J., Gill, N., & Mantzoros, C. S. (2013) · Metabolism · doi:10.1016/j.metabol.2013.04.014 · Cited by 46
Vaccarin ameliorates insulin resistance and steatosis by activating the AMPK signaling pathway
Lei, Y., Gong, L., Tan, F., Liu, Y., Li, S., Shen, H., Zhu, M. P., Cai, W., Xu, F., Hou, B., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.029 · Cited by 45
Lipin Deficiency Impairs Diurnal Metabolic Fuel Switching
Xu, J., Lee, W. N. P., Phan, J., Saad, M. F., Reue, K., & Kurland, I. J. (2006) · Diabetes · doi:10.2337/db06-0260 · Cited by 46
Maiorana, A., Bianco, C. D., & Cianfarani, S. (2007) · The Review of Diabetic Studies · doi:10.1900/rds.2007.4.134 · Cited by 47
Lourido, F., Quenti, D., Salgado-Canales, D., & Tobar, N. (2021) · Scientific Reports · doi:10.1038/s41598-021-82944-4 · Cited by 48
Pessler, D., Pekala, P. H., Kovsan, J., Bloch-Damti, A., Rudich, A., & Bashan, N. (2006) · Archives of Physiology and Biochemistry · doi:10.1080/13813450500500399 · Cited by 49
Is There Glucose Production Outside of the Liver and Kidney?
Previs, S. F., Brunengraber, D. Z., & Brunengraber, H. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141134 · Cited by 45
Oxidized LDL impair adipocyte response to insulin by activating serine/threonine kinases
Scazzocchio, B., Varı́, R., D’Archivio, M., Santangelo, C., Filesi, C., Giovannini, C., & Masella, R. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800402-jlr200 · Cited by 49
Haluzı́k, M., Dietz, K. R., Kim, J. K., Marcus‐Samuels, B., Shulman, G. I., Gavrilova, O., & Reitman, M. L. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2113 · Cited by 45
Self-citationInsulin Resistance in Tetracycline-Repressible Munc18c Transgenic Mice
Spurlin, B. A., Thomas, R. M., Nevins, A. K., Kim, H.-J., Kim, Y., Noh, H. L., Shulman, G. I., Kim, J. K., & Thurmond, D. C. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1910 · Cited by 43
Self-citationLipids in the Wrong Place: Visceral Fat and Nonalcoholic Steatohepatitis
Perseghin, G. (2011) · Diabetes Care · doi:10.2337/dc11-s249 · Cited by 45
Wang, L., Pydi, S. P., Zhu, L., Barella, L. F., Cui, Y., Gavrilova, O., Bence, K. K., Vernochet, C., & Wess, J. (2020) · Nature Communications · doi:10.1038/s41467-020-16756-x · Cited by 43
Self-citationLei, Z., Wu, H., Yang, Y., Hu, Q. C., Lei, Y., Liu, W., Nie, Y., Yang, L., Zhang, X., Yang, C., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.708838 · Cited by 42
Abulizi, A., Perry, R. J., Camporez, J. P. G., Jurczak, M. J., Petersen, K. F., Aspichueta, P., & Shulman, G. I. (2017) · The FASEB Journal · doi:10.1096/fj.201700001r · Cited by 41
Self-citationAl-Mrabeh, A. H. (2021) · Biomedicines · doi:10.3390/biomedicines9020226 · Cited by 43
L-CARNITINE ADMINISTRATION PREVENTS OXIDATIVE STRESS IN HIGH FRUCTOSE-FED INSULIN RESISTANT RATS
Nagar, A., Rajasekar, P., Subramanian, K., & Anuradha, C. V. (2005) · Cited by 41
Cellular mechanism of insulin resistance in skeletal muscle.
Petersen, K. F., & Shulman, G. I. (2002) · Europe PMC (PubMed Central) · Cited by 40
Self-citationChen, W., Zhou, H., Saha, P., Li, L., & Chan, L. (2014) · Endocrinology · doi:10.1210/en.2014-1292 · Cited by 39
Ding, X., Fan, S., Lu, Y., Zhang, Y., Gu, M., Zhang, L., Liu, G., Guo, L., Jiang, D., Lu, X., et al. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/678592 · Cited by 41
Pleotropic effects of leptin to reverse insulin resistance and diabetic ketoacidosis
Perry, R. J., Petersen, K. F., & Shulman, G. I. (2016) · Diabetologia · doi:10.1007/s00125-016-3909-4 · Cited by 39
Self-citationLu, Y., Xi, W., Ding, X., Fan, S., Zhang, Y., Jiang, D., Li, Y., Huang, C., & Zhou, Z. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms141223736 · Cited by 40
Haluzı́k, M., Gavrilova, O., & LeRoith, D. (2003) · Endocrinology · doi:10.1210/en.2003-1015 · Cited by 39
Self-citationWang, P., Kuo, H., Huang, H., Chang, A. Y., Weng, S., Tai, M., Chuang, J., Chen, I., Huang, S., Lin, T., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5334 · Cited by 38
Sterol regulatory element-binding protein (SREBP)-1: gene regulatory target for insulin resistance?
Kotzka, J., & Müller‐Wieland, D. (2004) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.8.2.141 · Cited by 37
The role of increased liver triglyceride content: a culprit of diabetic hyperglycaemia?
Song, S. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.260 · Cited by 37
Bonnefond, A., & Semple, R. K. (2022) · Diabetologia · doi:10.1007/s00125-022-05720-7 · Cited by 40
Auguet, T., Guiu‐Jurado, E., Berlanga, A., Terra, X., Martínez, S., Porras, J. A., Ceausu, A., Sabench, F., Hernández, M., Aguilar, C., et al. (2014) · Obesity · doi:10.1002/oby.20809 · Cited by 36
Li, Y., Shrestha, Y. B., Chen, M., Chanturiya, T., Gavrilova, O., & Weinstein, L. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1517142113 · Cited by 35
Self-citationKuwabara, T., Mori, K., Mukoyama, M., Kasahara, M., Yokoi, H., & Nakao, K. (2013) · Clinical and Experimental Nephrology · doi:10.1007/s10157-013-0922-5 · Cited by 33
Emerging paradigms for understanding fatness and diabetes risk
Smith, S. R., & Ravussin, É. (2002) · Current Diabetes Reports · doi:10.1007/s11892-002-0087-1 · Cited by 34
Enhanced intra-abdominal visceral fat accumulation in patients with Werner's syndrome
Mori, S., Murano, S., Yokote, K., Takemoto, M., Asaumi, S., Take, A., & Saito, Y. (2001) · International Journal of Obesity · doi:10.1038/sj.ijo.0801529 · Cited by 33
Resistance training prevents liver fat accumulation in ovariectomized rats
Corriveau, P., Paquette, A., Brochu, M., Prud’homme, D., RABASA-LHORET, R. P. R., & Lavoie, J.-M. (2008) · Maturitas · doi:10.1016/j.maturitas.2008.02.005 · Cited by 33
Adipocyte Gq signaling is a regulator of glucose and lipid homeostasis in mice
Kimura, T., Pydi, S. P., Wang, L., Haspula, D., Cui, Y., Lü, H., König, G. M., Kostenis, E., Steinberg, G. R., Gavrilova, O., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29231-6 · Cited by 35
Self-citationOverexpression of muscle lipoprotein lipase and insulin sensitivity
Pulawa, L. K., & Eckel, R. H. (2002) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-200209000-00017 · Cited by 32
Fat Targets for Insulin Signaling
Czech, M. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00509-9 · Cited by 36
Song, D., Bandsma, R., Xiao, C., Xi, L., Shao, W., Jin, T., & Lewis, G. F. (2011) · Diabetologia · doi:10.1007/s00125-011-2082-z · Cited by 30
Adipose Tissue as Endocrine Organ
Sinal, C. J., & Goralski, K. B. (2009) · Oxidative stress and disease · doi:10.1201/9781420091311.ch2 · Cited by 33
Johanson, E. H., Jansson, P., Lönn, L., Matsuzawa, Y., Funahashi, T., Taskinen, M., Smith, U., & Axelsen, M. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021961 · Cited by 30
Sinaiko, A. R., & Caprio, S. (2012) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2012.01.012 · Cited by 28
American College of Endocrinology Pre-Diabetes Consensus Conference: Part Two
Bloomgarden, Z. T. (2008) · Diabetes Care · doi:10.2337/dc08-zb11 · Cited by 26
Girard, J. R. (2003) · médecine/sciences · doi:10.1051/medsci/20031989827 · Cited by 35
Obesity: an epidemic in need of therapeutics
der Ploeg, L. H. T. V. (2000) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(00)00114-9 · Cited by 27
Saponin as regulator of biofuel: implication for ethnobotanical management of diabetes
Elekofehinti, O. O., Omotuyi, O. I., Kamdem, J. P., Ejelonu, O. C., Olher, V. G. A., Adanlawo, I. G., & da Rocha, J. B. T. (2014) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-014-0325-4 · Cited by 27
Immune cells and metabolic dysfunction
Eheim, A. L., Medříková, D., & Herzig, S. (2013) · Seminars in Immunopathology · doi:10.1007/s00281-013-0403-7 · Cited by 27
Type 2 Diabetes With Partial Lipodystrophy of the Limbs
Strickland, L. R., Guo, F., Lok, K. H., & Garvey, W. T. (2013) · Diabetes Care · doi:10.2337/dc12-1529 · Cited by 25
Carbone, F., Mach, F., Pontremoli, R., Viazzi, F. C., & Montecucco, F. (2013) · Thrombosis and Haemostasis · doi:10.1160/th13-06-0499 · Cited by 25
Bruder-Nascimento, T. B., Kress, T. C., & de Chantemèle, E. J. B. (2019) · F1000Research · doi:10.12688/f1000research.20150.1 · Cited by 23
Leptin in Relation to the Lipodystrophy-Associated Metabolic Syndrome
Mantzoros, C. S. (2012) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2012.36.3.181 · Cited by 22
The molecular basis of genetic lipodystrophies
Bhayana, S., & Hegele, R. A. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00297-7 · Cited by 23
Laha, A., Majumder, A., Singh, M., & Tyagi, S. C. (2018) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2018-0037 · Cited by 23
Guerra, C. E., Navarro, P., Valverde, Á. M., Arribas, M., Brüning, J. C., Kozak, L. P., Kahn, C. R., & Benito, M. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113103 · Cited by 22
Kim, D. H., Sartor, M. A., Bain, J. R., Sandoval, D. A., Stevens, R. D., Medvedovic, M., Newgard, C. B., Woods, S. C., & Seeley, R. J. (2012) · Diabetes · doi:10.2337/db11-1579 · Cited by 21
Hunt, B. G., Wang, Y.-L., Chen, M.-S., Wang, S.-C., & Waltz, S. E. (2017) · Environmental Research · doi:10.1016/j.envres.2017.09.004 · Cited by 21
den Bosch, J. D. V., Hoeks, J., Timmers, S., Houten, S. M., van Dijk, P., Boon, W., van Beurden, D., Schaart, G., Kersten, S., Voshol, P. J., et al. (2010) · Obesity · doi:10.1038/oby.2010.152 · Cited by 20
Guiu‐Jurado, E., Auguet, T., Berlanga, A., Aragonès, G., Aguilar, C., Sabench, F., Armengol, S., Porras, J. A., Martí, A., Jorba, R., et al. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161226206 · Cited by 23
Duan, S., Usher, M. G., Foley, E. L., Milstone, D. S., Brosius, F. C., & Mortensen, R. M. (2010) · Diabetologia · doi:10.1007/s00125-010-1748-2 · Cited by 20
Insulin Resistance in Type 2 Diabetes
Roden, M., Petersen, K. F., & Shulman, G. I. (2016) · Wiley eBooks · doi:10.1002/9781118924853.ch13 · Cited by 20
Self-citationInsulin-like growth factor binding protein-3 links obesity and breast cancer progression
Scully, T., Firth, S. M., Scott, C. D., de Silva, H. C., Pintar, J. E., Chan‐Ling, T., Twigg, S. M., & Baxter, R. C. (2016) · Oncotarget · doi:10.18632/oncotarget.10675 · Cited by 22
Beneficial metabolic role of β-arrestin-1 expressed by AgRP neurons
Pydi, S. P., Cui, Z., He, Z., Barella, L. F., Pham, J., Cui, Y., Oberlin, D. J., EĞRİTAĞ, H. E., Urs, N. M., Gavrilova, O., et al. (2020) · Science Advances · doi:10.1126/sciadv.aaz1341 · Cited by 20
Self-citationβ-arrestin-1 suppresses myogenic reprogramming of brown fat to maintain euglycemia
Pydi, S. P., Jain, S., Barella, L. F., Zhu, L., Sakamoto, W., Meister, J., Wang, L., Lü, H., Cui, Y., Gavrilova, O., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba1733 · Cited by 18
Self-citationAdipocyte Biology from the Perspective of In Vivo Research: Review of Key Transcription Factors
Evseeva, M. N., Balashova, M. S., Kulebyakin, K. Y., & Rubtsov, Y. P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010322 · Cited by 21
Somatic, Biochemical and Hepatic Alterations in Wild Type Mice Chronically Fed High Fat Diet
Neves, R. H., Alencar, A. C. M. D. B., Águila, M. B., Mandarim‐de‐Lacerda, C. A., Machado-Silva, J. R., & Gomes, D. C. (2006) · International Journal of Morphology · doi:10.4067/s0717-95022006000500018 · Cited by 18
Geng, T., Zhao, X., Xia, L., Liu, L., Li, F., Yang, B., Wang, Q., Montgomery, S. A., Cui, H., & Gong, D. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.05.149 · Cited by 19
Werner syndrome as a possible cause of non-alcoholic steatohepatitis
Hashizume, H., Sato, K., Takagi, H., Kanda, D., Kashihara, T., Kiso, S., & Mori, M. (2009) · Journal of Clinical Pathology · doi:10.1136/jcp.2009.070680 · Cited by 18
Courtney, C. H., & Olefsky, J. M. (2007) · Springer eBooks · doi:10.1007/978-0-387-72204-7_10 · Cited by 22
Yasari, S., Prud’homme, D., Tesson, F., Jankowski, M., Gutkowska, J., Levy, E. H., & Lavoie, J.-M. (2011) · Journal of Nutrition and Metabolism · doi:10.1155/2012/181687 · Cited by 16
Choi, E. M., Suh, K. S., Jung, W., Park, S. Y., Chin, S. O., Rhee, S. Y., Pak, Y. K., & Chon, S. (2018) · Journal of Applied Toxicology · doi:10.1002/jat.3664 · Cited by 15
Metadata
- Authors
- Kim, J. K., Gavrilova, O., Chen, Y., Reitman, M. L., & Shulman, G. I.
- Affiliations
- Howard Hughes Medical Institute (US)
- National Institutes of Health (US)
- Corresponding author
- Shulman, Gerald I.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2000-03
- Volume
- 275
- Issue
- 12
- Pages
- 8456-8460
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2111445543
- Cited by
- 443
- References
- 30
- Citations by year
- 2026: 3 · 2025: 3 · 2024: 7 · 2023: 4 · 2022: 8 · 2021: 13 · 2020: 12 · 2019: 15 · 2018: 10 · 2017: 19 · 2016: 18 · 2015: 18 · 2014: 14 · 2013: 19 · 2012: 17
- FWCI
- 25.12
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- Eli Lilly and Company
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK45735, R01-DK40936, R01DK040936, P30DK045735)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- insulin resistance, type 2 diabetes, IRS-1, insulin receptor substrate 2, phosphatidylinositol 3-kinase, insulin signaling, liver triglyceride accumulation, fat partitioning, fat transplantation, hyperinsulinemic-euglycemic clamp
- MeSH terms
- Adipose Tissue, Animals, Body Composition, Insulin, Insulin Resistance, Liver, Mice, Mutant Strains, Mice, Transgenic, Muscles, Phosphoproteins, Transcription Factors, Glucose Clamp Technique, Phosphatidylinositol 3-Kinases, Intracellular Signaling Peptides and Proteins, Mice, Insulin Receptor Substrate Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review